Showing results (531-540 of 8,884) with videos related to
Sort By:
Pageof 889
Schizophrenia Research|October 24, 2000
Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcomeR Tandon, J R DeQuardo, S F Taylor, et al.Schizophrenia Research|October 24, 2000
Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaireO Kampman, K Lehtinen, V Lassila, et al.Schizophrenia Research|October 24, 2000
Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophreniaM O Krebs, A Gut-Fayand, M Bourdel, et al.Schizophrenia Research|December 11, 1999
Differential olanzapine plasma concentrations by sex in a fixed-dose studyD L Kelly, R R Conley, C A TammingaSchizophrenia Research|December 11, 1999
Measuring neuroleptic-induced akathisia by three-channel actometryK Tuisku, H Lauerma, M Holi, et al.Schizophrenia Research|December 11, 1999
An event-related potential study in schizophrenia using Japanese sentencesK Ohta, M Uchiyama, E Matsushima, et al.Schizophrenia Research|June 27, 2000
Brain and ventricle instability during psychotic episodes of the schizophreniasD L Garver, T R Nair, J D Christensen, et al.Schizophrenia Research|June 27, 2000
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjectsA Vita, M Dieci, C Silenzi, et al.Schizophrenia Research|June 27, 2000
Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up studyJ Addington, D AddingtonSchizophrenia Research|February 20, 2003
Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcomeVinay Parikh, Denise R Evans, Mohammad M Khan, et al.Pageof 889